Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Aduro BioTech, Inc. News

Biotech Movers: Minerva, XBiotech, Aduro

Minerva Neurosciences, XBiotech and Aduro Biotech were among the biotech movers in premarket trading on Thursday.

Aduro Biotech to team with Merck on second trial this year

Aduro Biotech and Merck will team on two separate trials featuring Aduro's CRS-207 and Merck's Keytruda to explore treatments for mesothelioma and gastric cancer.

3 stocks setting up for major breakouts

Here's how to rake in the gains off some potential major breakouts.

Trump's drug pricing comment sends biotech stocks into free-fall

There's little to substantiate the president-elect's claim that he will bring drug prices down, but biotech investors are trading anyway.

Aduro Biotech (ADRO) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Aduro Biotech (ADRO) as a strong on high relative volume candidate

Breaking News

Morgan Stanley Stock Leads Gains As Banks Boost Dividends After Fed Stress Tests

Morgan Stanley, Wells Fargo, Bank of America and Goldman Sachs will lift their quarterly dividend, while JPMorgan will hold its steady following last week's Fed stress tests.

Nike Stock Slides As As Margin Pressures, China Worries Offset Q4 Earnings Beat

"We think we're well positioned for growth in fiscal year 2023 ... having said that, we did take a cautious approach to Greater China," said CFO Matthew Friend.

Playtika Stock Slumps After Joffre Capital Takes 25.7% Stake Online Casino Gaming Group

Axios reported late Monday that tech buyout group Joffre Capital is seeking a majority stake in the online casino video game group.

Walgreens Stock Slides As Group Scraps Plan to Sell UK-based Boots

"As a result of market instability ... no third party has been able to make an offer that adequately reflects the high potential value of Boots," Walgreens said.